Cardiovascular benefits and improved patient survival by rosuvastatin treatment in hemodialyis patients are determined by normalization of CRP and LDL-cholesterol - A prospective analyis of the AURORA trial.
(English)Manuscript (preprint) (Other academic)
Urology and Nephrology
Research subject Medicine
IdentifiersURN: urn:nbn:se:uu:diva-153729OAI: oai:DiVA.org:uu-153729DiVA: diva2:417699